Page 9 - Kristen Zannella News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Applied BioMath, LLC to Present at PEGS Summit

Applied BioMath, LLC to Present at PEGS Summit News provided by Share this article CONCORD, Mass., May 4, 2021 /PRNewswire/ Applied BioMath ( www.appliedbiomath.com), the industry-leader in applying systems pharmacology and mechanistic modeling, simulation, and analysis to de-risk drug research and development today announced their participation at the PEGS Summit occurring virtually May 11-13, 2021. John Burke, PhD, Co-founder, President and CEO of Applied BioMath will present Applied BioMath Assess™ - An Early Feasibility Assessment Tool for Biotherapeutics within the conference program, Advancing Bispecific Antibodies and Combination Therapy to the Clinic on Tuesday, May 11th at 10:40 a.m. ET. In this presentation, Dr. Burke will demonstrate how Applied BioMath s new and interactive software tool systematically investigates the therapeutic characteristics (e.g., format, half-life, affinity, mechanism of action) given target characteristics (e.g., target expression and

Lucia willeJohn burkeKristen zannellaApplied biomathBiomath assessEarly feasibility assessment toolAdvancing bispecific antibodiesCombination therapyMulti specific antibody designMechanistic avidityEngineering bispecific antibodiesலூசியா வில்லேஜான் பர்க்சேர்க்கை சிகிச்சை

Applied BioMath, LLC to Hold Virtual Quantitative Systems Pharmacology Summit April 6th-8th

Share this article Share this article CONCORD, Mass., March 9, 2021 /PRNewswire/ Applied BioMath (www.appliedbiomath.com), the industry-leader in applying systems pharmacology and mechanistic modeling, simulation, and analysis to de-risk therapy research and development, today announced they will host a virtual Quantitative Systems Pharmacology (QSP) Summit Tuesday, April 6th - Thursday, April 8th occurring 11 a.m. - 1 p.m. ET each day. The QSP Summit is an annual meeting dedicated to fostering an active community of industry and academic participants interested in utilizing computational biology approaches including QSP modeling. Registrants are encouraged to submit a poster abstract for the virtual poster session. Undergraduate and graduate students as well as postdocs are eligible to receive poster prizes with first place receiving $150, second place receiving $100, and third place receiving $50. Six poster abstracts will be selected for lightning presentations during the ev

Samuel isaacsonMike rosenblattRaman singhSergio iadevaiaJohn burkeKristen zannellaStudent at university buffaloProfessor at boston universityQuantitative systems pharmacologySummit tuesdayYuan changGraduate studentScientific directorData analysisAssociate professorSenior clinical pharmacokineticist

Applied BioMath, LLC Announces Collaboration with Immunitas Therapeutics

Applied BioMath, LLC Announces Collaboration with Immunitas Therapeutics News provided by Share this article Share this article CONCORD, Mass., March 2, 2021 /PRNewswire/ Applied BioMath (www.appliedbiomath.com), the industry-leader in applying systems pharmacology and mechanistic modeling, simulation, and analysis to de-risk drug research and development, today announced their collaboration with Immunitas Therapeutics, Inc. (www.immunitastx.com) for the development of a systems pharmacology model for an oncology pathway with complex receptor-ligand dynamics. The model will be used to understand the importance of targeting multiple receptors simultaneously and will inform the optimal therapeutic modality. Efficiently translating early research into a clinical candidate is a top priority at Immunitas, said Tarek Samad, CSO of Immunitas. We look forward to leveraging Applied BioMath s mathematical models to better understand the best path forward for this therapeutic program.

John burkeKristen zannellaTarek samadImmunitas therapeutics incImmunitas therapeuticsApplied biomathஜான் பர்க்தரெக் சமத்

Applied BioMath, LLC Announces Collaboration with Immunitas Therapeutics

Applied BioMath, LLC Announces Collaboration with Immunitas Therapeutics
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

John burkeKristen zannellaTarek samadImmunitas therapeutics incImmunitas therapeuticsApplied biomathஜான் பர்க்தரெக் சமத்

Applied BioMath, LLC Announces that Revitope Oncology is extending its Collaboration on Systems Pharmacology Modeling in Solid Tumors

Applied BioMath, LLC Announces that Revitope Oncology is extending its Collaboration on Systems Pharmacology Modeling in Solid Tumors News provided by Share this article Share this article CONCORD, Mass., Feb. 9, 2021 /PRNewswire/ Applied BioMath (www.appliedbiomath.com), the industry-leader in applying systems pharmacology and mechanistic modeling, simulation, and analysis to de-risk drug research and development, today announced that Revitope Oncology is extending its collaboration to develop a systems pharmacology model for Revitope s dual antigen targeting TwoGATE™ platform for solid tumor indications. Our previous collaborations with Applied BioMath proved extremely valuable as we leveraged their models to identify optimal therapeutic parameters in our development process, said Werner Meier, CSO of Revitope Oncology. We look forward to extending our prior collaboration with this project to help accelerate our lead pipeline candidate towards the clinic. In this coll

United kingdomWerner meierJohn burkeKristen zannellaRevitope oncology incRevitope oncologyApplied biomathஒன்றுபட்டது கிஂக்டம்வெர்னர் மையர்ஜான் பர்க்